InnoCare Pharma Limited (SHA:688428)
25.01
-0.21 (-0.83%)
At close: Jul 7, 2025, 2:57 PM CST
InnoCare Pharma Revenue
InnoCare Pharma had revenue of 381.26M CNY in the quarter ending March 31, 2025, with 129.92% growth. This brings the company's revenue in the last twelve months to 1.22B, up 71.32% year-over-year. In the year 2024, InnoCare Pharma had annual revenue of 1.01B with 36.68% growth.
Revenue (ttm)
1.22B
Revenue Growth
+71.32%
P/S Ratio
20.56
Revenue / Employee
1.12M
Employees
1,089
Market Cap
25.18B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |